{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["AKT", "Anti-inflammatory activity", "Chrysanthemum indicum var. albescens", "Macrophage", "NF-\u03baB"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "28274893", "DateCompleted": {"Year": "2017", "Month": "06", "Day": "06"}, "DateRevised": {"Year": "2022", "Month": "03", "Day": "31"}, "Article": {"ArticleDate": [{"Year": "2017", "Month": "03", "Day": "06"}], "Language": ["eng"], "ELocationID": ["10.1016/j.jep.2017.03.001", "S0378-8741(16)32192-4"], "Journal": {"ISSN": "1872-7573", "JournalIssue": {"Volume": "201", "PubDate": {"Year": "2017", "Month": "Apr", "Day": "06"}}, "Title": "Journal of ethnopharmacology", "ISOAbbreviation": "J Ethnopharmacol"}, "ArticleTitle": "AKT-targeted anti-inflammatory activity of the methanol extract of Chrysanthemum indicum var. albescens.", "Pagination": {"StartPage": "82", "EndPage": "90", "MedlinePgn": "82-90"}, "Abstract": {"AbstractText": ["Wild chrysanthemum (Chrysanthemum indicum) is one of well-known medicinal plants traditionally used in Korea and China. As a variant of wild chrysanthemum, white wild chrysanthemum (Chrysanthemum indicum var. albescens) is also ethnopharmacologically applied to treat various symptoms such as inflammatory diseases.", "Although the anti-inflammatory activity of Chrysanthemum indicum has been reported, the anti-inflammatory activity and underlying molecular mechanism of white wild chrysanthemum are poorly understood.", "The effects of Chrysanthemum indicum var. albescens methanol extract (Civ-ME) on the production of inflammatory mediators, expression of pro-inflammatory genes, cell viability, and the activities of intracellular signaling molecules and transcription factors were investigated in lipopolysaccharide (LPS)-stimulated RAW264.7 cells.", "Civ-ME suppressed the production of both nitric oxide (NO) and prostaglandin E<sub>2</sub> (PGE<sub>2</sub>) without cytotoxicity in LPS-stimulated RAW264.7 cells. Civ-ME was found to reduce the mRNA levels of inflammatory genes such as inducible NO synthase (iNOS) and tumor necrosis factor (TNF)-\u03b1 and reduced NF-\u03baB-mediated transcriptional activation. Civ-ME inhibited the nuclear translocation of NF-\u03baB (p65 and p50), and its upstream signaling composed of I\u03baB\u03b1 and IKK\u03b1/\u03b2. An NF-\u03baB luciferase reporter gene assay and an in vitro kinase assay confirmed that AKT1 and AKT2 might be direct pharmacological targets of Civ-ME. In addition, luteolin was identified by HPLC analysis as the main active pharmacological components of Civ-ME.", "Civ-ME exerts an anti-inflammatory effect by targeting AKT1 and AKT2 in the NF-\u03baB signaling pathway in macrophage-mediated inflammatory responses."], "CopyrightInformation": "Copyright \u00a9 2017 Elsevier Ireland Ltd. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Genetic Engineering, Sungkyunkwan University, Suwon 16419, Republic of Korea. Electronic address: real0902@gmail.com."}], "LastName": "Yang", "ForeName": "Woo Seok", "Initials": "WS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Heritage Material Research Team, Amorepacific R&D Unit, Yongin 446-729, Republic of Korea. Electronic address: dhkim417@amorepacific.com."}], "LastName": "Kim", "ForeName": "Donghyun", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Engineering, Cheongju University, Cheongju 28503, Republic of Korea. Electronic address: ysyi@cju.ac.kr."}], "LastName": "Yi", "ForeName": "Young-Su", "Initials": "YS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Genetic Engineering, Sungkyunkwan University, Suwon 16419, Republic of Korea. Electronic address: kjhmlkjhml@hanmail.net."}], "LastName": "Kim", "ForeName": "Ji Hye", "Initials": "JH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Genetic Engineering, Sungkyunkwan University, Suwon 16419, Republic of Korea. Electronic address: you8755@nate.com."}], "LastName": "Jeong", "ForeName": "Hye Yoon", "Initials": "HY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Heritage Material Research Team, Amorepacific R&D Unit, Yongin 446-729, Republic of Korea. Electronic address: khhwang@amorepacific.com."}], "LastName": "Hwang", "ForeName": "Kyeonghwan", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physiology, College of Veterinary Medicine, Chonbuk National University, Iksan 54596, Republic of Korea. Electronic address: jhkim1@chonbuk.ac.kr."}], "LastName": "Kim", "ForeName": "Jong-Hoon", "Initials": "JH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Heritage Material Research Team, Amorepacific R&D Unit, Yongin 446-729, Republic of Korea. Electronic address: superbody@amorepacific.com."}], "LastName": "Park", "ForeName": "Junseong", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Genetic Engineering, Sungkyunkwan University, Suwon 16419, Republic of Korea. Electronic address: jaecho@skku.edu."}], "LastName": "Cho", "ForeName": "Jae Youl", "Initials": "JY"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Ireland", "MedlineTA": "J Ethnopharmacol", "NlmUniqueID": "7903310", "ISSNLinking": "0378-8741"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Lipopolysaccharides"}, {"RegistryNumber": "0", "NameOfSubstance": "NF-kappa B"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Solvents"}, {"RegistryNumber": "0", "NameOfSubstance": "Tumor Necrosis Factor-alpha"}, {"RegistryNumber": "31C4KY9ESH", "NameOfSubstance": "Nitric Oxide"}, {"RegistryNumber": "EC 1.14.13.39", "NameOfSubstance": "Nitric Oxide Synthase Type II"}, {"RegistryNumber": "K7Q1JQR04M", "NameOfSubstance": "Dinoprostone"}, {"RegistryNumber": "Y4S76JWI15", "NameOfSubstance": "Methanol"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}, {"QualifierName": [], "DescriptorName": "Chrysanthemum"}, {"QualifierName": ["metabolism"], "DescriptorName": "Dinoprostone"}, {"QualifierName": [], "DescriptorName": "HEK293 Cells"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Lipopolysaccharides"}, {"QualifierName": ["chemistry"], "DescriptorName": "Methanol"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["metabolism"], "DescriptorName": "NF-kappa B"}, {"QualifierName": ["metabolism"], "DescriptorName": "Nitric Oxide"}, {"QualifierName": ["genetics"], "DescriptorName": "Nitric Oxide Synthase Type II"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "RAW 264.7 Cells"}, {"QualifierName": ["chemistry"], "DescriptorName": "Solvents"}, {"QualifierName": ["genetics"], "DescriptorName": "Tumor Necrosis Factor-alpha"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2016", "Month": "11", "Day": "30"}, {"Year": "2017", "Month": "2", "Day": "24"}, {"Year": "2017", "Month": "3", "Day": "1"}, {"Year": "2017", "Month": "3", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "6", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "3", "Day": "10", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["28274893", "10.1016/j.jep.2017.03.001", "S0378-8741(16)32192-4"]}}]}